Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.
A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.
Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.
A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.
Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.
A British woman with an incurable cancer has broken the world record for rowing across the Atlantic, raising thousands for Cancer Research UK.
The charity publishes its gender and ethnicity pay gap reports.
3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.
A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).
The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.